Brainsway (BWAY) Current Deferred Revenue (2018 - 2026)
Brainsway (BWAY) posted quarterly Current Deferred Revenue of $9.9 million for Q1 2026, up 34.88% year-on-year from $7.3 million in Q1 2025, and down 6.06% on a QoQ basis from $10.6 million in Q4 2025.
Brainsway (BWAY) Current Deferred Revenue (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Current Deferred Revenue for 9 consecutive years, with $9.9 million the latest figure, recorded in Q1 2026.
- Quarterly Current Deferred Revenue rose 34.88% year-over-year to $9.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.9 million (up 34.88% YoY) and the FY2025 annual result came in at $10.6 million, up 137.96% from the prior year.
- Current Deferred Revenue fell to $9.9 million in Q1 2026 per BWAY's latest filing, from $10.6 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for BWAY reached as high as $15.6 million in Q2 2025 and fell as low as $1.5 million in Q4 2022.
- A 5-year average of $5.5 million and a median of $4.4 million in 2024 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue slumped 32.71% — and 2025, when it surged 218.27%.
- Year by year, Current Deferred Revenue stood at $1.5 million in 2022, then jumped by 69.53% to $2.5 million in 2023, then surged by 77.08% to $4.4 million in 2024, then soared by 137.96% to $10.6 million in 2025, then dropped by 6.06% to $9.9 million in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $9.9 million, $10.6 million, and $13.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.91 Mn |
| Dec 31, 2025 | 10.55 Mn |
| Sep 30, 2025 | 13.62 Mn |
| Jun 30, 2025 | 15.65 Mn |
| Mar 31, 2025 | 7.35 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 4.82 Mn |
| Jun 30, 2024 | 4.92 Mn |
| Mar 31, 2024 | 5.48 Mn |
| Dec 31, 2023 | 2.50 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 1.98 Mn |
| Mar 31, 2023 | 2.26 Mn |
| Dec 31, 2022 | 1.48 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 1.97 Mn |
| Mar 31, 2022 | 2.24 Mn |
| Dec 31, 2021 | 2.20 Mn |
| Sep 30, 2021 | 1.63 Mn |
| Jun 30, 2021 | 1.56 Mn |